VERICI DX PLC

Post-Annual General Meeting Information • Jul 30, 2025

National Storage Mechanism | Additional information

RNS Number : 0851T

Verici Dx PLC

30 July 2025

Verici Dx plc

("Verici Dx" or the "Company")

Result of Annual General Meeting

Verici Dx Plc, (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, announces that at the Annual General Meeting ("AGM") held yesterday, all resolutions were duly passed.

The voting results of the AGM were as follows:

	In Favour		Against		Withheld
Resolution	Votes	%	Votes	%	Votes
1	469,065,903	99.98	88,290	0.02	24,006
2	468,421,915	99.85	718,633	0.15	37,651
3	469,047,227	99.98	106,783	0.02	24,189
4	469,057,547	100.00	21,408	0.00	99,244
5	468,889,463	99.96	189,044	0.04	99,692

Verici Dx plc	www.vericidx.com
Sara Barrington, CEO	Via Walbrook PR
Singer Capital Markets (Nominated adviser, Joint Broker and Joint Bookrunner)		Tel: +44 (0)20 7496 3000
Phil Davies / Sam Butcher
Oberon Capital (Joint Broker and Joint Bookrunner)	Tel: +44 (0)20 3179 0500
Mike Seabrook / Adam Pollock / Jessica Cave
Walbrook PR (Media & Investor Relations)	Tel: +44 (0)20 7933 8780 or vericidx@walbrookpr.com
Alice Woodings / Paul McManus	Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGBKLLLEDLEBBE